=== ALLERGIES ===
Allergen (clinical drug ingredient)
Drug/Non Drug Allergy documented on EMR
Reaction
Allergy Type
Onset Date
Status
All nuts (uncoded)
anaphylaxis
Allergy
Active
Environmental, seasonal (uncoded)
nasal congestion, rhinorrhea, HA, asthma
Allergy
Active
Seafood
Seafood (uncoded)
anaphylaxis
Allergy
Active
Levaquin
anaphylaxis
Drug Allergy
Active
atorvastatin
Lipitor
hives
Drug Allergy
Active


=== RESULTS ===
No Results


=== REASON FOR REFERRAL ===
No Information


=== REASON FOR VISIT ===
Lab review


=== MEDICATIONS ===
Medication
SIG (Take, Route, Frequency, Duration)
Notes
Start Date
End Date
Status
NexIUM 40 MG
1 capsule Orally Once a day
Unknown
busPIRone HCl 10 MG
1 tablet Orally Twice a day
Unknown
Vitamin D 50 MCG (2000 UT)
1 tablet Orally Once a day
Unknown
Omeprazole 40 MG
1 capsule 30 minutes before morning meal Orally Once a day
Unknown
Ibuprofen 800 MG
1 tablet with food or milk as needed Orally every 8 hrs
Unknown
Ondansetron HCl 4 MG
1 tablet Orally Once a day; Duration: 30 day(s)
PRN
06/11/2024
Unknown
Benzonatate 100 MG
1 capsule as needed Orally Three times a day
02/09/2024
Unknown
Levocetirizine Dihydrochloride 5 MG
1 tablet in the evening Orally Once a day; Duration: 30 days
07/18/2025
08/17/2025
Active
Benzonatate 100 MG
1 capsule as needed orally Three times a day; Duration: 14 day(s)
01/31/2024
Unknown
metroNIDAZOLE 1 %
1 application Externally Once a day; Duration: 30 days
07/01/2025
07/31/2025
Active
Repatha 140 MG/ML
1 mL Subcutaneous every other week; Duration: 30 days
05/15/2024
Unknown
Albuterol Sulfate HFA 108 (90 Base) MCG/ACT
1 puff as needed Inhalation every 4 hrs
Unknown
hydrOXYzine HCl 10 MG
1 tablet as needed Orally Once a day
PRN
Unknown
Singulair 10 MG
1 tablet Orally Once a day
Unknown
Xanax 0.5 MG
1 tablet Orally Twice a day
Unknown
Calcium
Unknown
Vitamin C
Unknown
methIMAzole 5 MG
1 tablet Orally Once a day
Unknown
Juven -
as directed Orally
Unknown
Lidocaine 4 %
1 patch as needed Externally Once a day
Unknown
Probiotic
Unknown
Theratears
0.25% solution
Unknown
Fluticasone Propionate 50 MCG/ACT
2 sprays in each nostril Nasally Once a day
Unknown
Loratadine 10 MG
1 tablet Orally Once a day
Unknown
Budesonide-Formoterol Fumarate 160-4.5 MCG/ACT
2 puffs Inhalation Twice a day
Unknown


=== IMMUNIZATIONS ===
No Information


=== SOCIAL HISTORY ===
No Information


=== PROBLEMS ===
Problem Type
SNOMED Code
ICD Code
Onset Dates
Problem Status
W/U Status
Risk
Notes
Problem
Vitamin B>12< deficiency anaemia (49472006)
Vitamin B12 deficiency anemia, unspecified (D51.9)
Active
confirmed
Problem
Hyperprolactinemia (237662005)
Hyperprolactinemia (E22.1)
Active
confirmed
Problem
Hyperlipidemia (55822004)
Hyperlipidemia, unspecified (E78.5)
Active
confirmed
Problem
Restless legs syndrome (32914008)
Restless legs syndrome (G25.81)
Active
confirmed
Problem
Rheumatoid lung disease (398726004)
Rheumatoid lung disease with rheumatoid arthritis of unspecified site (M05.10)
Active
confirmed
Problem
Paresthesia (finding) (91019004)
Paresthesia of skin (R20.2)
Active
confirmed
Problem
hypercholesterolemia (disorder) (13644009)
Hypercholesteremia (E78.00)
Active
confirmed
Problem
Venous insufficiency of leg (disorder) (234050002)
Venous insufficiency (I87.2)
Active
confirmed
Problem
Essential hypertension (59621000)
Hypertension, unspecified type (I10)
Active
confirmed
Problem
Hyperlipidaemia (55822004)
Hyperlipidemia, unspecified hyperlipidemia type (E78.5)
Active
confirmed
Problem
Claudication (63491006)
Claudication (I73.9)
Active
confirmed
Problem
Hypothyroidism (40930008)
Hypothyroidism, unspecified type (E03.9)
Active
confirmed
Problem
Asthma without status asthmaticus (55570000)
Asthma, unspecified asthma severity, unspecified whether complicated, unspecified whether persistent (J45.909)
Active
confirmed
Problem
Vitamin D deficiency (34713006)
Vitamin D deficiency (E55.9)
Active
confirmed
Problem
Anxiety (48694002)
Anxiety (F41.9)
Active
confirmed
Problem
Lupus anticoagulant disorder (19267009)
Lupus anticoagulant disorder (D68.62)
Active
confirmed
Problem
Pain at rest of bilateral lower limbs due to atherosclerosis (disorder) (12236991000119103)
Rest pain of both lower extremities due to atherosclerosis (I70.223)
Active
confirmed
Problem
Skin sensation disturbance (80910005)
Tingling of both feet (R20.2)
Active
confirmed
Problem
Burning sensation of skin (762397008)
Burning sensation of skin (R20.8)
Active
confirmed


=== VITAL SIGNS ===
No Information


=== PROCEDURES ===
No Information


=== ENCOUNTERS ===
Encounter
Location
Date
Provider
Diagnosis
Epic Heart And Vascular Care
4 HDSN VLY PROF PLZ STE B NEWBURGH, NY 12550-3157
07/19/2025
Shellene Napier-Martin
Leg swelling M79.89 ; Person consulting for explanation of examination or test findings Z71.2 ; Asthma, unspecified asthma severity, unspecified whether complicated, unspecified whether persistent J45.909 ; Acute sinusitis, unspecified J01.90 ; Pain in leg, unspecified M79.606 ; Abnormal level of hormones in specimens from female genital organs R87.1 ; Disorder of thyroid, unspecified E07.9 ; Hormone replacement therapy Z79.890 ; Vitamin B deficiency, unspecified E53.9 ; Raised antibody titer R76.0 ; Elevated erythrocyte sedimentation rate R70.0 ; Lupus anticoagulant disorder D68.62 ; Lyme disease A69.20 ; Hyperprolactinemia E22.1 ; Rheumatoid lung disease with rheumatoid arthritis of unspecified site M05.10 ; Hypothyroidism, unspecified type E03.9 ; Flushing R23.2 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Rash and nonspecific skin eruption R21 ; Deficiency of other specified B group vitamins E53.8 ; Vitamin B12 deficiency anemia, unspecified D51.9 ; Former smoker Z87.891 ; Hypercholesteremia E78.00 ; Vitamin D deficiency E55.9 ; Claudication I73.9 ; Hypertension, unspecified type I10 ; Rest pain of both lower extremities due to atherosclerosis I70.223 ; Anxiety F41.9 ; Palpitations R00.2 ; Fatigue, unspecified type R53.83 ; Leg heaviness R29.898 ; Leg numbness R20.0 ; Blurred vision H53.8 ; Ocular pain, unspecified eye H57.10 ; Paresthesia of skin R20.2 ; Anesthesia of skin R20.0 ; Tingling of both feet R20.2 ; Decreased pedal pulses R09.89 ; Restless legs syndrome G25.81 ; Cold feet R20.9 ; Burning sensation of skin R20.8 ; Dizziness R42 and Venous insufficiency I87.2


=== MEDICAL EQUIPMENT ===
No Information


=== ASSESSMENTS ===
Encounter Date
Diagnosis (ICD Code)
Treatment Notes
Section Notes
encounter date : 07/19/2025
Leg swelling (ICD-10 - M79.89)
encounter date : 07/19/2025
Person consulting for explanation of examination or test findings (ICD-10 - Z71.2)
encounter date : 07/19/2025
Asthma, unspecified asthma severity, unspecified whether complicated, unspecified whether persistent (ICD-10 - J45.909)
encounter date : 07/19/2025
Acute sinusitis, unspecified (ICD-10 - J01.90)
encounter date : 07/19/2025
Pain in leg, unspecified (ICD-10 - M79.606)
encounter date : 07/19/2025
Abnormal level of hormones in specimens from female genital organs (ICD-10 - R87.1)
encounter date : 07/19/2025
Disorder of thyroid, unspecified (ICD-10 - E07.9)
encounter date : 07/19/2025
Hormone replacement therapy (ICD-10 - Z79.890)
encounter date : 07/19/2025
Vitamin B deficiency, unspecified (ICD-10 - E53.9)
encounter date : 07/19/2025
Raised antibody titer (ICD-10 - R76.0)
encounter date : 07/19/2025
Elevated erythrocyte sedimentation rate (ICD-10 - R70.0)
encounter date : 07/19/2025
Lupus anticoagulant disorder (ICD-10 - D68.62)
encounter date : 07/19/2025
Lyme disease (ICD-10 - A69.20)
encounter date : 07/19/2025
Hyperprolactinemia (ICD-10 - E22.1)
encounter date : 07/19/2025
Rheumatoid lung disease with rheumatoid arthritis of unspecified site (ICD-10 - M05.10)
encounter date : 07/19/2025
Hypothyroidism, unspecified type (ICD-10 - E03.9)
encounter date : 07/19/2025
Flushing (ICD-10 - R23.2)
encounter date : 07/19/2025
Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)
encounter date : 07/19/2025
Rash and nonspecific skin eruption (ICD-10 - R21)
encounter date : 07/19/2025
Deficiency of other specified B group vitamins (ICD-10 - E53.8)
encounter date : 07/19/2025
Vitamin B12 deficiency anemia, unspecified (ICD-10 - D51.9)
encounter date : 07/19/2025
Former smoker (ICD-10 - Z87.891)
encounter date : 07/19/2025
Hypercholesteremia (ICD-10 - E78.00)
encounter date : 07/19/2025
Vitamin D deficiency (ICD-10 - E55.9)
encounter date : 07/19/2025
Claudication (ICD-10 - I73.9)
encounter date : 07/19/2025
Hypertension, unspecified type (ICD-10 - I10)
encounter date : 07/19/2025
Rest pain of both lower extremities due to atherosclerosis (ICD-10 - I70.223)
encounter date : 07/19/2025
Anxiety (ICD-10 - F41.9)
encounter date : 07/19/2025
Palpitations (ICD-10 - R00.2)
encounter date : 07/19/2025
Fatigue, unspecified type (ICD-10 - R53.83)
encounter date : 07/19/2025
Leg heaviness (ICD-10 - R29.898)
encounter date : 07/19/2025
Leg numbness (ICD-10 - R20.0)
encounter date : 07/19/2025
Blurred vision (ICD-10 - H53.8)
encounter date : 07/19/2025
Ocular pain, unspecified eye (ICD-10 - H57.10)
encounter date : 07/19/2025
Paresthesia of skin (ICD-10 - R20.2)
encounter date : 07/19/2025
Anesthesia of skin (ICD-10 - R20.0)
encounter date : 07/19/2025
Tingling of both feet (ICD-10 - R20.2)
encounter date : 07/19/2025
Decreased pedal pulses (ICD-10 - R09.89)
encounter date : 07/19/2025
Restless legs syndrome (ICD-10 - G25.81)
encounter date : 07/19/2025
Cold feet (ICD-10 - R20.9)
encounter date : 07/19/2025
Burning sensation of skin (ICD-10 - R20.8)
encounter date : 07/19/2025
Dizziness (ICD-10 - R42)
encounter date : 07/19/2025
Venous insufficiency (ICD-10 - I87.2)
encounter date : 07/19/2025
Other
Her
labs, including thyroid function, FSH, LH, CRP, ESR, rheumatoid
factor, estradiol, progesterone, serotonin, prolactin, triptase,
estrogen, lupus panel, and B12, were all within normal limits. We
will continue monitoring her energy levels and hormone balance. She
is advised to maintain her current medications. All questions and
concerns answered and addressed. Heart healthy diet and healthy
lifestyle modifications were encouraged and endorsed. Patient is in
agreement with the plan.
Patient was informed of the telemedicine visit by our office staff. Telemedicine was described in detail to the patient as the use of synchronous video and audio communication to provide clinical care from a distance. A telemedicine visit can provide the same medical standard of care for specific conditions. The patient was informed that the practice staff located at the provider's office would assist in carrying out any recommendations and clinical care.
Patient Location: Home
Lack of strict HIPPA Rules. Patient expressed verbal interest in the telemedicine visit and granted consent to proceed.


=== PLAN OF TREATMENT ===
Treatment Notes
Assessment
Notes
Other
Her
labs, including thyroid function, FSH, LH, CRP, ESR, rheumatoid
factor, estradiol, progesterone, serotonin, prolactin, triptase,
estrogen, lupus panel, and B12, were all within normal limits. We
will continue monitoring her energy levels and hormone balance. She
is advised to maintain her current medications. All questions and
concerns answered and addressed. Heart healthy diet and healthy
lifestyle modifications were encouraged and endorsed. Patient is in
agreement with the plan.
Patient was informed of the telemedicine visit by our office staff. Telemedicine was described in detail to the patient as the use of synchronous video and audio communication to provide clinical care from a distance. A telemedicine visit can provide the same medical standard of care for specific conditions. The patient was informed that the practice staff located at the provider's office would assist in carrying out any recommendations and clinical care.
Patient Location: Home
Lack of strict HIPPA Rules. Patient expressed verbal interest in the telemedicine visit and granted consent to proceed.
Next Appt
Details
Follow Up: As scheduled, Reason:
Provider Name:MARION HAYES, 09/16/2025 09:15:00 AM, 528 East Main St, MIDDLETOWN, NY, 10940-2632, 877-374-2362
Provider Name:RISHI BAJAJ, 09/19/2025 04:00:00 PM, 528 East Main St, MIDDLETOWN, NY, 10940-2632, 877-374-2362


=== GOALS SECTION ===
No Information


=== HEALTH CONCERNS ===
No Information


=== INSURANCE PROVIDERS ===
Payer Name
Payer Address
Payer Phone
Subscriber Number
Group Number
Insured Name
Patient Relationship to Insured
Coverage Start Date
Coverage End Date
Aetna Health
PO BOX 981106 EL PASO, TX 79998-1107
102026205700
Diaz, Maria
Self - patient is the insured
Affinity by Molina Healthcare NY
PO BOX 22615 LONG BEACH, CA 90801-5637
800-223-7242
AQ06345C
Diaz, Maria
Self - patient is the insured
Medicare of New York  Downstate  J13
PO BOX 6178 INDIANAPOLIS, IN 462066178
866-837-0241
1AK5QK4DM86
Diaz, Maria
Self - patient is the insured
Medicaid of New York
PO BOX 4601 RENSSELAER, NY 121444602
AQ06345C
Diaz, Maria
Self - patient is the insured


=== HISTORY AND PHYSICAL NOTES ===
HPI (History of Present Illness)
Category
Sub-Category
Detail
Notes
Category Notes
Transition of Care
This is a 63-year-old female, former smoker, with a history of asthma, anemia, HLD, hypothyroidism and anxiety, who presents today for a cardiovascular follow-up via TMV for lab review. She reports ongoing fatigue, with some improvement after B12 injections. She remains on hormone replacement therapy. She denies any chest pain, dyspnea, dizziness, or syncopal episodes.
Venous reflux study: Significant reflux in bilateral GSV
Echocardiogram: LVEF 55-60%, mild pulmonary hypertension with PASP of 30 mmHg.
BLE arterial doppler: Significant stenosis with possible infrapopliteal bilateral stenosis.
Carotid doppler:  Mild plaque.
AAA screen: Mild-to-moderate plaque, no significant evidence of abdominal uretic aneurysm.
Peripheral angiogram; 02/12/25; right femoral artery access revealing RSFA 40% stenosis and LSFA 50% stenosis.
BLE arterial doppler: Patent flow.
Venous reflux:  Mild reflux and no significant DVT.
Her labs, including thyroid function, FSH, LH, CRP, ESR, rheumatoid factor, estradiol, progesterone, serotonin, prolactin, triptase, estrogen, lupus panel, and B12, were all within normal limits. We will continue monitoring her energy levels and hormone balance. She is advised to maintain her current medications. All questions and concerns answered and addressed. Heart healthy diet and healthy lifestyle modifications were encouraged and endorsed. Patient is in agreement with the plan.


